Delivery Order SPE2DB20D2104-SPE2DB21FQ91K
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for pharmaceutical and medical supply distribution to support the Defense Logistics Agency (DLA) Troop Support Medical. The $15,286.20 delivery order falls under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 held by Cencora, Inc. with the DLA, which runs through November 2026. This IDC enables the efficient procurement of a comprehensive range of pharmaceutical products and...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the provision of pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA) Troop Support Medical. The $9,780.35 delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA, which serves as the primary vehicle for delivering a comprehensive range of medications, devices, and other medical commodities to support...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for pharmaceutical and medical supply distribution in support of the Defense Logistics Agency (DLA) Troop Support Medical. The $8,432.68 delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA, which runs through November 2026. This IDC enables the efficient procurement of a comprehensive range of pharmaceutical products and medical supplies,...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for a prime vendor pharmaceutical support contract with the Defense Logistics Agency (DLA). The $11,870.26 delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical, which runs through November 2026. This IDC serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., provides pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA) Troop Support Medical. The $23,800.57 delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA that runs through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of essential medical commodities, including specialty...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for pharmaceutical and medical supply distribution services. The $1,778.62 delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 between the DLA Troop Support Medical and Cencora, Inc. The IDC, which runs through November 2026, enables the DLA to efficiently procure a comprehensive range of essential medical...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for pharmaceutical and medical supply distribution services to support the Defense Logistics Agency (DLA) Troop Support Medical. The $1,492.80 delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA, which provides a comprehensive range of pharmaceutical products and medical supplies to military treatment facilities, veterans' healthcare...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for pharmaceutical and medical supply distribution to support the Defense Logistics Agency (DLA) Troop Support Medical program. The $16,949.74 Delivery Order was issued under a $999,999,999.00 Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA, which runs through November 2026. This IDC enables the DLA to efficiently procure a comprehensive range of pharmaceutical products and...
- The federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for pharmaceutical and medical supply distribution services to support the Defense Logistics Agency (DLA) Troop Support Medical. The $6,677.45 delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA that runs through November 2026. This IDC enables the DLA to efficiently procure a comprehensive range of pharmaceutical products and medical supplies, including...
- This federal contract award is for a pharmaceutical prime vendor contract with the Defense Logistics Agency (DLA) Troop Support Medical, awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,070.64 delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB21FQ91KDelivery Order
This federal contract award to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) provides a prime vendor pharmaceutical distribution solution for the Defense Logistics Agency (DLA). The $9,639.02 delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which runs through November 2026. This IDC enables the efficient procurement of a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions worldwide. The contract award does not have a set-aside designation, indicating open competition. In addition to the DLA IDC, Cencora, Inc. also holds a smaller $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs through May 2024.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.6k | 11/3/20 |